28 related articles for article (PubMed ID: 33049840)
1. Genetic polymorphism of CYP1A2 but not total or free teriflunomide concentrations is associated with leflunomide cessation in rheumatoid arthritis.
Hopkins AM; Wiese MD; Proudman SM; O'Doherty CE; Upton RN; Foster DJ
Br J Clin Pharmacol; 2016 Jan; 81(1):113-23. PubMed ID: 26331989
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic activity and biodistribution of a nano-sized polymer-dexamethasone conjugate intended for the targeted treatment of rheumatoid arthritis.
Rubanová D; Skoroplyas S; Libánská A; Randárová E; Bryja J; Chorvátová M; Etrych T; Kubala L
Nanomedicine; 2024 Jan; 55():102716. PubMed ID: 38738529
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-Mimetic, ROS Responsive, and Oxygen Generating Nanovesicles for Targeted Interventions of Refractory Rheumatoid Arthritis.
Tang Z; Meng S; Yang X; Xiao Y; Wang W; Liu Y; Wu K; Zhang X; Guo H; Zhu YZ; Wang X
Small; 2023 Dec; ():e2307379. PubMed ID: 38084463
[TBL] [Abstract][Full Text] [Related]
4. Synergistic chemotherapy/PTT/oxygen enrichment by multifunctional liposomal polydopamine nanoparticles for rheumatoid arthritis treatment.
Fu X; Song Y; Feng X; Liu Z; Gao W; Song H; Zhang Q
Asian J Pharm Sci; 2024 Feb; 19(1):100885. PubMed ID: 38434718
[TBL] [Abstract][Full Text] [Related]
5. Nanomaterial-assisted theranosis of bone diseases.
Zheng K; Bai J; Yang H; Xu Y; Pan G; Wang H; Geng D
Bioact Mater; 2023 Jun; 24():263-312. PubMed ID: 36632509
[TBL] [Abstract][Full Text] [Related]
6. Polycaprolactone based pharmaceutical nanoemulsion loaded with acriflavine: optimization and
Nawaz T; Iqbal M; Khan BA; Ahmed N; Nawaz A; Rasul A; Rizg WY; Jali AM; Ahmed RA; Safhi AY
Drug Deliv; 2022 Dec; 29(1):3233-3244. PubMed ID: 36299245
[TBL] [Abstract][Full Text] [Related]
7. Nano-Size Characterization and Antifungal Evaluation of Essential Oil Molecules-Loaded Nanoliposomes.
Aguilar-Pérez KM; Medina DI; Parra-Saldívar R; Iqbal HMN
Molecules; 2022 Sep; 27(17):. PubMed ID: 36080492
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic Production of Chondroitin Oligosaccharides and Its Sulfate Derivatives.
Zhang W; Xu R; Jin X; Wang Y; Hu L; Zhang T; Du G; Kang Z
Front Bioeng Biotechnol; 2022; 10():951740. PubMed ID: 35910011
[TBL] [Abstract][Full Text] [Related]
9. Development and Optimization of Acriflavine-Loaded Polycaprolactone Nanoparticles Using Box-Behnken Design for Burn Wound Healing Applications.
Nawaz T; Iqbal M; Khan BA; Nawaz A; Hussain T; Hosny KM; Abualsunun WA; Rizg WY
Polymers (Basel); 2021 Dec; 14(1):. PubMed ID: 35012125
[TBL] [Abstract][Full Text] [Related]
10. Insight Into Nanoliposomes as Smart Nanocarriers for Greening the Twenty-First Century Biomedical Settings.
Aguilar-Pérez KM; Avilés-Castrillo JI; Medina DI; Parra-Saldivar R; Iqbal HMN
Front Bioeng Biotechnol; 2020; 8():579536. PubMed ID: 33384988
[TBL] [Abstract][Full Text] [Related]
11. Selective Binding of Cyclodextrins with Leflunomide and Its Pharmacologically Active Metabolite Teriflunomide.
Terekhova I; Kritskiy I; Agafonov M; Kumeev R; Martínez-Cortés C; Pérez-Sánchez H
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33265979
[TBL] [Abstract][Full Text] [Related]
12. Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations.
Pandey S; Kumar V; Leekha A; Rai N; Ahmad FJ; Verma AK; Talegaonkar S
Pharm Res; 2018 Sep; 35(11):201. PubMed ID: 30187188
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronate-functionalized hydroxyapatite nanoparticles laden with methotrexate and teriflunomide for the treatment of rheumatoid arthritis.
Pandey S; Rai N; Mahtab A; Mittal D; Ahmad FJ; Sandal N; Neupane YR; Verma AK; Talegaonkar S
Int J Biol Macromol; 2021 Feb; 171():502-513. PubMed ID: 33422513
[TBL] [Abstract][Full Text] [Related]
14. Topical delivery of leflunomide for rheumatoid arthritis treatment: evaluation of local tissue deposition of teriflunomide and its anti-inflammatory effects in an arthritis rat model.
Bae J; Park JW
Drug Dev Ind Pharm; 2016; 42(2):254-62. PubMed ID: 26006334
[TBL] [Abstract][Full Text] [Related]
15. Design of chondroitin sulphate coated proglycosomes for localized delivery of tofacitinib for the treatment of rheumatoid arthritis.
Gorantla S; Rao Puppala E; Naidu VGM; Saha RN; Singhvi G
Eur J Pharm Biopharm; 2023 May; 186():43-54. PubMed ID: 36940886
[TBL] [Abstract][Full Text] [Related]
16. Improvement of experimental accelerated atherosclerosis by chondroitin sulphate.
Martínez-Calatrava MJ; Largo R; Herrero-Beaumont G
Osteoarthritis Cartilage; 2010 Jun; 18 Suppl 1():S12-6. PubMed ID: 20399896
[TBL] [Abstract][Full Text] [Related]
17. Facile functionalization of Teriflunomide-loaded nanoliposomes with Chondroitin sulphate for the treatment of Rheumatoid arthritis.
Mahtab A; Rabbani SA; Neupane YR; Pandey S; Ahmad A; Khan MA; Gupta N; Madaan A; Jaggi M; Sandal N; Rawat H; Aqil M; Talegaonkar S
Carbohydr Polym; 2020 Dec; 250():116926. PubMed ID: 33049840
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
